Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.
Open Access
- 1 July 1995
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 96 (1) , 394-400
- https://doi.org/10.1172/jci118047
Abstract
GSH peroxidase (Px) catalyzes the reduction of lipid hydroperoxides (LOOH), known metabolic products of platelets and vascular cells. Because interactions between these cells are modulated by nitric oxide (NO) and LOOH inactivate NO, we investigated the effect of GSH-Px on the inhibition of platelet function by the naturally occurring S-nitrosothiol, S-nitroso-glutathione (SNO-Glu). Concentrations of SNO-Glu that alone did not inhibit platelet function (subthreshold inhibitory concentrations) were added to platelet-rich plasma together with GSH-Px (0.2-20 U/ml); this led to a dose-dependent inhibition of platelet aggregation with an IC50 of 0.6 U/ml GSH-Px. In the presence of subthreshold inhibitory concentrations of SNO-Glu, the LOOH, 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid, increased platelet aggregation, an effect reversed by GSH-Px. Glutathione and SNO-Glu were equally effective as cosubstrates for GSH-Px. Incubation of SNO-Glu with GSH-Px for 1 min led to a 48.5% decrease in the concentration of SNO-Glu. Incubation of SNO-Glu with serum albumin led to the formation of S-nitroso-albumin, an effect enhanced by GSH-Px. These observations suggest that GSH-Px has two functions: reduction of LOOH, thereby preventing inactivation of NO, and metabolism of SNO-Glu, thereby liberating NO and/or supporting further transnitrosation reactions.Keywords
This publication has 32 references indexed in Scilit:
- The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumPublished by Elsevier ,2005
- The oxidation of low density lipoprotein by cells or iron is inhibited by zincFEBS Letters, 1994
- Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart diseaseAtherosclerosis, 1993
- Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis.Journal of Clinical Investigation, 1992
- Oxygen Radical Generation in Human Platelets: Dependence on 12-Lipoxygenase Activity and on the Glutathione CycleInternational Archives of Allergy and Immunology, 1990
- SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALSThe Lancet, 1989
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMPublished by Elsevier ,1987
- Hydroperoxy fatty acid formation in selenium deficient rat platelets: Coupling of glutathione peroxidase to the lipoxygenase pathwayBiochemical and Biophysical Research Communications, 1983
- Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acidBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- The level and half‐life of glutathione in human plasmaFEBS Letters, 1980